ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.

Evita M Lindholm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.